Expansion And GrowthThe growth in new beds and facilities is estimated to triple the contribution to same-store growth through 2026, which will significantly elevate durability and drive visibility into growth and margins.
Financial PerformanceQ1:24 adjusted EPS of $0.84 beat consensus estimates by +6%, while adjusted EBITDA of $174mm beat consensus estimates by +2%.
Market PositionThe stock now sells for below 10x forecasted 2025 EBITDA vs. its 3-year average of 12.8x, indicating a potential undervaluation.